FDA Advocacy
Learn about our work to bring the voice of people concerned about women’s health to decision-makers who create and implement health policies.
Featured Posts
Your Questions About the New COVID-19 Vaccines – Answered
By: Cindy Pearson and Sarah Christopherson COVID-19, FDA Advocacy Deep Dive ArticlesHow safe are the vaccines? How effective? Were they tested in people like me? Was the approval process influenced by political pressure? Here’s what we know.
COVID-19 and Experimental Drugs: Health Information
By: NWHN Staff COVID-19, FDA Advocacy Deep Dive ArticlesAs the United States nears the peak of the COVID-19 pandemic, it is natural to hope for treatments that can save lives. But when experimental drugs are promoted by a president who has consistently eschewed and misrepresented science, consumers and patients have to exercise caution.
An Open Letter to FDA’s New Commissioner
By: Cindy Pearson FDA Advocacy, FDA Commissioner Deep Dive ArticlesThe public pays for more than half of the FDA’s budget each year, which entitles us to have a say in the agency’s operations. Late last year, we gave your predecessor, Scott Gottlieb, a report card on his first year as Commissioner—he got mixed grades. Here’s what you could do to get all A’s on your report card.
FDA Meeting – Clinical Trial Diversity
By: Sarah Christopherson Clinical Trials, FDA Advocacy, Office of Women's Health (OWH), People of Color TestimonyFood and Drug Administration Safety and Innovation Act 907 Public Meeting: Progress on Enhancing the Collection, Analysis, and Availability of Demographic Subgroup Data
Browse our FDA ADVOCACY work:
Results for:
FDA Meeting – Emergency Use Authorization of the Johnson & Johnson/Janssen Biotech Inc. COVID-19 Vaccine
By: Sarah Christopherson ,COVID-19, FDA Advocacy, Vaccine TestimonyTestimony Delivered to the Vaccines and Related Biological Products Advisory Committee
Your Questions About the New COVID-19 Vaccines – Answered
By: Cindy Pearson and Sarah Christopherson ,COVID-19, FDA Advocacy Deep Dive ArticlesHow safe are the vaccines? How effective? Were they tested in people like me? Was the approval process influenced by political pressure? Here's what we know.
FDA Meeting – Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine
By: Sarah Christopherson ,COVID-19, FDA Advocacy TestimonyTestimony Delivered to the Vaccines and Related Biological Products Advisory Committee
FDA Meeting – Development, authorization and licensure of vaccines to prevent COVID-19
By: Sarah Christopherson ,COVID-19, FDA Advocacy TestimonyTestimony Delivered to the Vaccines and Related Biological Products Advisory Committee
FDA Comments — Office of Women’s Health Strategic Priorities
By: Sarah Christopherson ,Clinical Trials, FDA Advocacy TestimonyPublic comments urging the FDA's Office of Women’s Health to ensure that women’s needs are represented across FDA and in the agency’s research, education, and public outreach.
It’s Time to #MailTheAbortionPill
By: Sarah Christopherson ,Abortion, COVID-19, FDA Advocacy, Food and Drug Administration (FDA), Medication Abortion, Mifepristone Deep Dive ArticlesPatients are turning to telehealth appointments and online pharmacies for routine medical care during the COVID-19 outbreak without having to leave their homes. But for most pregnant people seeking safe and effective abortion pills, the FDA has created a Byzantine...
Lift Unnecessary Restrictions: Access to Medication Abortion During the COVID-19 Pandemic
By: M. Isabelle Chaudry ,Abortion, COVID-19, FDA Advocacy, Medication Abortion Deep Dive ArticlesThe NWHN is calling on the FDA to lift politically motivated, medically unnecessary restrictions on the abortion pill right now and let pregnant people receive the abortion pill through the mail so that they can get the pill where they...
The FDA’s Convoluted Stance on Abortion Pills Doesn’t Protect Patients — It Endangers Them
By: Sarah Christopherson and Olivia Snavely ,Abortion, FDA Advocacy, Medication Abortion, Mifeprex, Mifepristone Deep Dive ArticlesThe FDA says pregnant people can meet with their doctors remotely and have their abortion at home — but first, they must travel during a global pandemic just to pick up their pills.
COVID-19 and Experimental Drugs: Health Information
By: NWHN Staff ,COVID-19, FDA Advocacy Deep Dive ArticlesAs the United States nears the peak of the COVID-19 pandemic, it is natural to hope for treatments that can save lives. But when experimental drugs are promoted by a president who has consistently eschewed and misrepresented science, consumers and...
FDA Meeting – Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc
By: M. Isabelle Chaudry ,FDA Advocacy, Personal Care Products, Talc TestimonyU.S. Food & Drug Administration Public Meeting on Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc